BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9464355)

  • 1. Novel potent nonpeptide aminopeptidase N inhibitors with a cyclic imide skeleton.
    Miyachi H; Kato M; Kato F; Hashimoto Y
    J Med Chem; 1998 Jan; 41(3):263-5. PubMed ID: 9464355
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel small molecule nonpeptide aminopeptidase n inhibitors with a cyclic imide skeleton.
    Shimazawa R; Takayama H; Fujimoto Y; Komoda M; Dodo K; Yamasaki R; Shirai R; Koiso Y; Miyata K; Kato F; Kato M; Miyachi H; Hashimoto Y
    J Enzyme Inhib; 1999; 14(4):259-75. PubMed ID: 10445048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.
    Li Q; Fang H; Xu W
    Bioorg Med Chem Lett; 2007 May; 17(10):2935-8. PubMed ID: 17433673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Structure-based design, chemistry and activity evaluation. II.
    Li Q; Fang H; Wang X; Xu W
    Eur J Med Chem; 2010 Apr; 45(4):1618-26. PubMed ID: 20129718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of phthalimide-type histone deacetylase inhibitors.
    Shinji C; Nakamura T; Maeda S; Yoshida M; Hashimoto Y; Miyachi H
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4427-31. PubMed ID: 16137884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).
    Shang L; Wang Q; Fang H; Mu J; Wang X; Yuan Y; Wang B; Xu W
    Bioorg Med Chem; 2008 Dec; 16(23):9984-90. PubMed ID: 18996018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Design, chemistry and activity evaluation. Part I.
    Li Q; Fang H; Wang X; Hu L; Xu W
    Eur J Med Chem; 2009 Dec; 44(12):4819-25. PubMed ID: 19683842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.
    Tu G; Li S; Huang H; Li G; Xiong F; Mai X; Zhu H; Kuang B; Xu WF
    Bioorg Med Chem; 2008 Jul; 16(14):6663-8. PubMed ID: 18571419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New N-(phenoxydecyl)phthalimide derivatives displaying potent inhibition activity towards alpha-glucosidase.
    Pascale R; Carocci A; Catalano A; Lentini G; Spagnoletta A; Cavalluzzi MM; De Santis F; De Palma A; Scalera V; Franchini C
    Bioorg Med Chem; 2010 Aug; 18(16):5903-14. PubMed ID: 20667739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First synthesis of alpha-aminoalkyl-(N-substituted)thiocarbamoyl-phosphinates: inhibitors of aminopeptidase N (APN/CD13) with the new zinc-binding group.
    Grzywa R; Oleksyszyn J
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3734-6. PubMed ID: 18524593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
    Grembecka J; Mucha A; Cierpicki T; Kafarski P
    J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel amino-benzosuberone derivative is a picomolar inhibitor of mammalian aminopeptidase N/CD13.
    Maiereanu C; Schmitt C; Schifano-Faux N; Le Nouën D; Defoin A; Tarnus C
    Bioorg Med Chem; 2011 Sep; 19(18):5716-33. PubMed ID: 21843945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13.
    Bauvois B; Puiffe ML; Bongui JB; Paillat S; Monneret C; Dauzonne D
    J Med Chem; 2003 Aug; 46(18):3900-13. PubMed ID: 12930151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel hydroxamic acid-related phosphinates: inhibition of neutral aminopeptidase N (APN).
    Drag M; Grzywa R; Oleksyszyn J
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1516-9. PubMed ID: 17270439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of tryptase inhibitors derived from thalidomide.
    Tetsuhashi M; Ishikawa M; Hashimoto M; Hashimoto Y; Aoyama H
    Bioorg Med Chem; 2010 Jul; 18(14):5323-38. PubMed ID: 20561792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel alpha-glucosidase inhibitors with a tetrachlorophthalimide skeleton.
    Sou S; Mayumi S; Takahashi H; Yamasaki R; Kadoya S; Sodeoka M; Hashimoto Y
    Bioorg Med Chem Lett; 2000 May; 10(10):1081-4. PubMed ID: 10843222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-hydroxy-2-(naphthalene-2-ylsulfanyl)-acetamide, a novel hydroxamic acid-based inhibitor of aminopeptidase N and its anti-angiogenic activity.
    Lee J; Shim JS; Jung SA; Lee ST; Kwon HJ
    Bioorg Med Chem Lett; 2005 Jan; 15(1):181-3. PubMed ID: 15582436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Eur J Med Chem; 2008 Oct; 43(10):2130-9. PubMed ID: 18362041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino-benzosuberone: a novel warhead for selective inhibition of human aminopeptidase-N/CD13.
    Albrecht S; Al-Lakkis-Wehbe M; Orsini A; Defoin A; Pale P; Salomon E; Tarnus C; Weibel JM
    Bioorg Med Chem; 2011 Feb; 19(4):1434-49. PubMed ID: 21292493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-homo-amino acid scan of angiotensin IV.
    Lukaszuk A; Demaegdt H; Szemenyei E; Tóth G; Tymecka D; Misicka A; Karoyan P; Vanderheyden P; Vauquelin G; Tourwé D
    J Med Chem; 2008 Apr; 51(7):2291-6. PubMed ID: 18386881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.